Thursday, December 8, 2022

Biodefense

PharmAthene Reports First Quarter 2016 Financial and Operational Results

ANNAPOLIS, Md., May 9, 2016 - PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the first quarter of 2016. For the three months ended March 31, 2016,...
- Advertisement -

Latest News

The Baykar Bayraktar Kızılelma prototype took off the ground

Tests of the promising UAV Baykar Bayraktar Kızılelma are proceeding at an impressive pace. Two weeks ago, this drone...
- Advertisement -